We're off to the races!

FDA approves Viekira Pak to treat Hepatitis C

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.Hepatitis C is a viral disease that causes inflammation of the liver that can […]

Determined to Become a "Runner"

It is important for individuals with bleeding disorders to participate in some form of physical activity.  Being physically active helps to strengthen one’s muscles, bones and joints.  Having a strong healthy body can be a reduction in the number of bleeding episodes an individual might experience.  Many in the bleeding disorders community are championing the […]

en_USEnglish